Skip to main content
. 2023 Feb 27;13(4):e2934. doi: 10.1002/brb3.2934

TABLE 1.

Compilation of reports of neuro‐psychiatric manifestations of MPX

Serial no. First author Year of publication Country Study design Sample size Neurological manifestations Psychiatric manifestation Management Outcome Reference
1 Dimie Ogoina 2020 Nigeria Retrospective review of case records 40

Headache (19)

Myalgia (25)

Seizure (1)

Encephalitis (3)

Photophobia (9)

Anxiety (11)

Depression (11)

Suicide (1)

Symptomatic management and supportive care according to institutional guidelines.

Deaths (5)

Survival (35)

Ogoina et al., 2020
2 Dimie Ogoina 2019 Nigeria Cross‐sectional study 18

Headache (12)

Myalgia (5)

Pain (5)

Photophobia (3)

Suicide (1) According to institutional guidelines.

Deaths (1)

Survival (17)

Ogoina et al., 2019
3 Adesola Yinka‐Ogunleye 2019 Nigeria Review of the epidemiological report 118

Headache (61)

Myalgia (42)

Photophobia (27)

NA NA

Deaths (7)

Survival (111)

Yinka‐Ogunleye et al., 2019
4 S. Akar 2020 Nigeria Retrospective review of case records 165 Headache (78) NA NA

Deaths (9)

Survival (156)

Akar et al., 2020
5 E. E. Eseigbe 2021 Nigeria Case study 2 Headache (2) NA Both cases were admitted and treated with antibiotics, antihistamines, nonsteroidal anti‐inflammatory drugs, and multivitamins. Admitted and then discharged after treatment. Eseigbe et al., 2021
6 Christine M. Hughes 2021 Democratic Republic of Congo (DRC). Surveillance study 134

Headache (99)

Myalgia (90)

Fatigue (115)

NA NA NA Hughes et al., 2021
7 Phillip R. Pittman 2022 Democratic Republic of Congo (DRC). Prospective observational study 216

Headache (49)

Myalgia (15)

Dizziness (3)

Visual deficit (5)

Confusion (4)

Fatigue (11)

NA NA

Deaths (3)

Fetal deaths among admitted pregnant patients (four out of five patients)

Survival (213)

Pittman et al., 2022
8 Z. Ježek 1987 Zaire/DRC Surveillance study 282

Encephalitis (1)

Coma (1)

NA NA

Deaths (27)

Survival (32)

Jezek et al., 1987
9 Boumandouki P 2007 Democratic Republic of Congo (DRC). Surveillance study 81(8 confirmed) Myalgia (2) NA NA No deaths Boumandouki et al., 2007
10 E. Kalthan 2016 Central African Republic Descriptive study 12 Headache (2) NA NA Fatality (25%), about 67% in children less than 10 years of age Kalthan et al., 2016
11 Gregory D. Huhn 2005 United States Surveillance study 34

Headache (23)

Myalgia (19)

Seizure (1)

Confusion (2)

Encephalitis (1)

NA Nine patients were hospitalized and treated as inpatients, two of them were a 6‐year‐old girl and a 10‐year‐old girl admitted to intensive care unit. No deaths Huhn et al., 2005
12 Donita R. Croft 2007 United States Outbreak investigation and cohort study 19 Headache (13) NA NA No deaths Croft et al., 2007
13 Kurt D. Reed 2004 United States Outbreak investigation 11

Headache (11)

Myalgia (1)

NA

Four patients were hospitalized.

Nine patients received antibiotics (six received ciprofloxacin, and eight were given doxycycline). One patient received intravenous acyclovir, and two patients received valacyclovir. No patients received vaccinia immune globulin.

The disease was self‐limiting in all cases Reed et al., 2004
14 Mary G. Reynolds 2006 United States Review of outbreak 37

Headache (32)

Myalgia (36)

NA NA NA Reynolds et al., 2006
15 Michael G. Anderson 2003 United States Case report 1

Headache (1)

Myalgia (1)

Fatigue (1)

NA

Intravenous diphenhydramine, lorazepam, and morphine for oropharyngeal pain.

Intravenous ampicillin/sulbactam, 200 mg/kg/day divided every 6 h for the retropharyngeal phlegmon.

Bacitracin cream was applied on the facial lesions to minimize scarring.

Discharged after a week of admission. Anderson et al., 2003
16 James J. Sejvar 2004 United States Case series 3

Headache (2)

Seizure (1)

Altered mental status (1)

Delirium/encephalopathy (1)

Encephalitis (1)

NA One patient required lorazepam, intubation, and intensive care. She was given empiric intravenous ceftriaxone, acyclovir, phenobarbital, and midazolam.

Two patients did not require inpatient care and their disease remain self‐curing.

The third patient, a 6‐year‐old child was discharged after a 16‐day stay in the intensive care unit where she was intubated.

Sejvar et al., 2004
17 Hugh Adler 2022 United Kingdom Retrospective observational study 7

Headache (1)

Pain (1)

Low mood (3)

Emotional lability (1)

Two patients did not require any treatment.

A patient with low mood and emotional lability was given a psychological consult

Treatment of others varied between symptomatic management and antibiotic administration.

All seven of them recovered and survived. Adler et al., 2022
18 Lynne A. Learned 2005 Republic of Congo (ROC) Case series 11

Headache (1)

Fatigue (2)

Irritability (2)

Distress (4)

All but three of them required hospitalization.

Treatment varied between symptomatic management and hospitalization.

All 11 of them recovered. Bolanda et al., 2005
19 Mary G. Reynolds 2013 Republic of Congo (ROC) Surveillance study 2

Headache (1)

Fatigue (1)

NA NA NA Reynolds et al., 2013